AQIA (Aquiva Group) ROCE %: -115.12% (As of Sep. 2008)


What is Aquiva Group ROCE %?

Aquiva Group AQIA +36.41% ROCE % is -115.12% as of Sep. 2008.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Aquiva Group's annualized ROCE % for the quarter that ended in Sep. 2008 was -115.12%.

Aquiva Group  (OTCPK:AQIA) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Aquiva Group ROCE % Related Terms

Aquiva Group ROCE % Historical Data

* Premium members only.

The historical data trend for Aquiva Group's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aquiva Group ROCE % Chart

Aquiva Group Annual Data
Trend Mar06 Mar07 Mar08
ROCE %
-7.41 -203.64 -7.57

Aquiva Group Quarterly Data
Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.00 -65.60 32.01 -103.34 -115.12

Aquiva Group ROCE % Calculation

Aquiva Group's annualized ROCE % for the fiscal year that ended in Mar. 2008 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Mar. 2008 )  (A: Mar. 2007 )(A: Mar. 2008 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Mar. 2008 )  (A: Mar. 2007 )(A: Mar. 2008 )
=-0.136/( ( (0.002 - 0.001) + (8.044 - 4.45) )/ 2 )
=-0.136/( (0.001+3.594)/ 2 )
=-0.136/1.7975
=-7.57 %

Aquiva Group's ROCE % of for the quarter that ended in Sep. 2008 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Sep. 2008 )  (Q: Jun. 2008 )(Q: Sep. 2008 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Sep. 2008 )  (Q: Jun. 2008 )(Q: Sep. 2008 )
=-9.28/( ( (7.956 - 0) + (8.166 - 0) )/ 2 )
=-9.28/( ( 7.956 + 8.166 )/ 2 )
=-9.28/8.061
=-115.12 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2008) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -115.12% mean?
Aquiva Group (AQIA) has a ROCE % of -115.12% as of Sep. 2008.
Is Aquiva Group's ROCE % too high?
Aquiva Group's current ROCE % is -115.12%.
How does Aquiva Group's ROCE % compare to LOGQ and MUSS?
Aquiva Group's ROCE % of -115.12% can be compared against companies in the Software industry. The industry median ROCE % is 5.27. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Software company?
The median ROCE % among Software companies is 5.27, based on 2,711 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Software industry, the median ROCE % is 5.27 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aquiva Group's current ROCE % is -115.12%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aquiva Group stock overvalued right now?
Aquiva Group (AQIA) has a current ROCE % of -115.12%. The current ROCE % is -115.12%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Aquiva Group (AQIA), the current ROCE % is -115.12% as of Sep. 2008. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aquiva Group Business Description

Address No. 3 Bethesda Metro Center, Suite 700, Bethesda, MD, USA, 20814
Aquiva Group Inc is focused on commercializing materials science technologies in both existing and emerging markets. It has licensed a novel HiPNATM (Hydrogel with InterPenetrating Network Anchor) technology, branded as AquiFormTM, which is a versatile material with key properties, making it an attractive platform for various applications. These applications include transdermal patches that release active ingredients for skin care, nutraceuticals, and other healthcare and cosmetics markets. The company operates across three segments: Consumer Health, Wellness, & Cosmetics; Medical Device; and Therapeutics & Transdermal Drug-Delivery Systems (TDS). Additionally, it is building on an established partnership network and capabilities in contract development to expand its services to new areas.